Literature DB >> 7008864

Comparative density of the human T-cell antigen T65 on normal peripheral blood T cells and chronic lymphocytic leukemia cells.

S B Wormsley, M L Collins, I Royston.   

Abstract

A 65,000 dalton T-cell specific antigen previously demonstrated to be present on the surface of normal and malignant T cells, but not normal B cells, has been detected on the surface of leukemic cells from patients wih nonsecretory, surface immunoglobulin-positive chronic lymphocytic leukemia (CLL). By means of immunofluorescence and flow cytometry, the relative surface density of the T65 antigen on CLL cells was compared to that on normal peripheral blood T cells and human thymocytes, as well as cell lines of T-cell lineage. In all cases, the CLL cells had a more homogeneous and a lower median fluorescence intensity than that of normal circulating T cells. Thymocytes were composed of three populations, two with low surface density of T65 resembling the CLL cells and the other with higher density similar to normal T cells. The staining of cell lines varied from bright, heterogeneous staining (8402) to uniform, low-density staining (Molt-4). The implications of these findings with regard to lymphocyte differentiation are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7008864

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Cell-marker studies in CLL with monoclonal OKT antisera and lactic dehydrogenase isoenzyme analysis.

Authors:  L Sabbe; J Plum; M De Smedt; G Leroux; A Louwagie; A Criel
Journal:  Blut       Date:  1983-05

2.  Crossreaction of monoclonal anti-T-cell antibodies: implications for classifying B-cell leukemias.

Authors:  R Munker; E Thiel; U Kummer; H Rodt; S Thierfelder
Journal:  Blut       Date:  1983-02

3.  Expression of a T-cell antigen (Leu-1) by B-cell lymphomas.

Authors:  B F Burns; R A Warnke; R S Doggett; R V Rouse
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

4.  Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis.

Authors:  D A Cheresh; C J Honsik; L K Staffileno; G Jung; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

5.  Complete suppression of in vivo growth of human leukemia cells by specific immunotoxins: nude mouse models.

Authors:  H Hara; B K Seon
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.

Authors:  D A Cheresh; M D Pierschbacher; M A Herzig; K Mujoo
Journal:  J Cell Biol       Date:  1986-03       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.